The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for <i>In Vivo</i> Antitumor Activity
Michael Hudecek(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Stanley R. Riddell(University of Washington)
Cited by 517
Related Papers
ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models
|JCI Insight|2019|192
Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
|Journal for ImmunoTherapy of Cancer|2020|142
Signaling via a CD27-TRAF2-SHP-1 axis during naive T cell activation promotes memory-associated gene regulatory networks
|Immunity|2024|38
Design of sensitive monospecific and bispecific synthetic chimeric T cell receptors for cancer therapy
|Nature Cancer|2025|15
Sensitive bispecific chimeric T cell receptors for cancer therapy
|Research Square|2024|1